List of works by Shelly K. Sapp

Aspirin dose and six-month outcome after an acute coronary syndrome

scientific article (publication date: 17 March 2004)

Complementary Clinical Benefits of Coronary-Artery Stenting and Blockade of Platelet Glycoprotein IIb/IIIa Receptors

article

Elevated creatine kinase-MB with normal creatine kinase predicts worse outcomes in patients with acute coronary syndromes: results from 4 large clinical trials

scientific article published in January 2006

Glycoprotein IIb-IIIa inhibition with abciximab and postprocedural risk assessment: Lessons from the evaluation of platelet IIb/IIIa inhibitor for stenting trial and implication for ad hoc use of glycoprotein IIb-IIIa antagonists

scientific article published on 01 April 2002

Mortality benefit of beta blockade in patients with acute coronary syndromes undergoing coronary intervention: pooled results from the Epic, Epilog, Epistent, Capture and Rapport Trials

scientific article published in August 2003

Multi-year follow-up of abciximab therapy in three randomized, placebo-controlled trials of percutaneous coronary revascularization

scientific article published in July 2002

Prevalence of conventional risk factors in patients with coronary heart disease

scientific article

Reduction in vascular access site bleeding in sequential abciximab coronary intervention trials

article

Regional Variation across the United States in the Management of Acute Myocardial Infarction

article

Triple antiplatelet therapy during percutaneous coronary intervention is associated with improved outcomes including one-year survival: results from the Do Tirofiban and ReoProGive Similar Efficacy Outcome Trial (TARGET)

scientific article (publication date: October 2003)

Triple antiplatelet therapy during percutaneous coronary intervention is associated withimproved outcomes including one-year survival

article by Albert W Chan et al published October 2003 in Journal of the American College of Cardiology